ANGO vs DOCU · rev $292.5M vs P/E 15, rev $2.98B
AngioDynamics Inc (ANGO) versus DocuSign Inc (DOCU) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
DocuSign Inc (DOCU) is a software - application company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported DOCU revenue for 2025-01-31 was $2.98B. Net income was $1.07B. Revenue was up 7.8% from 2024-01-31 to 2025-01-31. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
ANGO currently screens at market cap $378.5M. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Not investment advice. Open the ANGO and DOCU stock pages for the full models.
Not investment advice.